期刊
TRENDS IN MOLECULAR MEDICINE
卷 22, 期 9, 页码 758-768出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.molmed.2016.07.004
关键词
-
资金
- Italian Liver Foundation
- Children's Mercy Hospital of Kansas City
- Czech Ministry of Health [RVO-VFN64165/2013]
- Czech Ministry of Education [PRVOUK-P25/LF1/2]
Unconjugated bilirubin (UCB) is known to be one of the most potent endogenous antioxidant substances. While hyperbilirubinemia has long been recognized as an ominous sign of liver dysfunction, recent data strongly indicate that mildly elevated bilirubin (BLB) levels can be protective against an array of diseases associated with increased oxidative stress. These clinical observations are supported by new discoveries relating to the role of BLB in immunosuppression and inhibition of protein phosphorylation, resulting in the modulation of intracellular signaling pathways in vascular biology and cancer, among others. Collectively, the evidence suggests that targeting BLB metabolism could be considered a potential therapeutic approach to ameliorate a variety of conditions.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据